Skip to main content
. 2016 Sep 8;6:32747. doi: 10.1038/srep32747

Figure 1. Structure of the different TNF inhibitors.

Figure 1

Adalimumab (ADL) is a fully human IgG1 kappa antibody, as is golimumab (GOL). Certolizumab pegol (CZP) is a pegylated humanized Fab’ fragment, infliximab (IFX) a chimeric antibody, and etanercept (ETN) a receptor-Fc construct. Human origin is shown in grey, murine origin in black.